154 related articles for article (PubMed ID: 33329059)
1. Mitochondria as Targets for Endothelial Protection in COVID-19.
Chernyak BV; Popova EN; Zinovkina LA; Lyamzaev KG; Zinovkin RA
Front Physiol; 2020; 11():606170. PubMed ID: 33329059
[No Abstract] [Full Text] [Related]
2. Mitochondria-targeted antioxidants as a therapeutic strategy for protecting endothelium in cardiovascular diseases.
Apostolova N; Rocha M; Rovira-Llopis S; Banuls C; Falcon R; Castello R; Hernandez-Mijares A; Victor VM
Curr Med Chem; 2014; 21(25):2989-3006. PubMed ID: 24934349
[TBL] [Abstract][Full Text] [Related]
3. Dysfunction of Kidney Endothelium after Ischemia/Reperfusion and Its Prevention by Mitochondria-Targeted Antioxidant.
Jankauskas SS; Andrianova NV; Alieva IB; Prusov AN; Matsievsky DD; Zorova LD; Pevzner IB; Savchenko ES; Pirogov YA; Silachev DN; Plotnikov EY; Zorov DB
Biochemistry (Mosc); 2016 Dec; 81(12):1538-1548. PubMed ID: 28259131
[TBL] [Abstract][Full Text] [Related]
4. Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis.
Dhanasekaran A; Kotamraju S; Kalivendi SV; Matsunaga T; Shang T; Keszler A; Joseph J; Kalyanaraman B
J Biol Chem; 2004 Sep; 279(36):37575-87. PubMed ID: 15220329
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy.
Victor VM; Apostolova N; Herance R; Hernandez-Mijares A; Rocha M
Curr Med Chem; 2009; 16(35):4654-67. PubMed ID: 19903143
[TBL] [Abstract][Full Text] [Related]
6. [Aerobic metabolism and reactive oxygen species in endothelial cells].
Koziel A; Jarmuszkiewicz W
Postepy Biochem; 2013; 59(4):386-94. PubMed ID: 24745169
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen and targeted antioxidant administration in endothelial cell mitochondria.
O'Malley Y; Fink BD; Ross NC; Prisinzano TE; Sivitz WI
J Biol Chem; 2006 Dec; 281(52):39766-75. PubMed ID: 17060316
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and endothelial dysfunction in cardiovascular disease: mitochondria-targeted therapeutics.
Rocha M; Apostolova N; Hernandez-Mijares A; Herance R; Victor VM
Curr Med Chem; 2010; 17(32):3827-41. PubMed ID: 20858217
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria-Targeted Antioxidant SkQR1 Reduces TNF-Induced Endothelial Permeability in vitro.
Galkin II; Pletjushkina OY; Zinovkin RA; Zakharova VV; Chernyak BV; Popova EN
Biochemistry (Mosc); 2016 Oct; 81(10):1188-1197. PubMed ID: 27908243
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria-targeted antioxidants prevent TNFα-induced endothelial cell damage.
Galkin II; Pletjushkina OY; Zinovkin RA; Zakharova VV; Birjukov IS; Chernyak BV; Popova EN
Biochemistry (Mosc); 2014 Feb; 79(2):124-30. PubMed ID: 24794727
[TBL] [Abstract][Full Text] [Related]
11. Endothelial mitochondria and heart disease.
Davidson SM
Cardiovasc Res; 2010 Oct; 88(1):58-66. PubMed ID: 20558442
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria-Targeted Antioxidants for Treatment of Hearing Loss: A Systematic Review.
Fujimoto C; Yamasoba T
Antioxidants (Basel); 2019 Apr; 8(4):. PubMed ID: 31022870
[TBL] [Abstract][Full Text] [Related]
13. [Endothelial mitochondria--a novel target for pharmacology of endothelial dysfunction].
Wrzosek A; Łojek A; Stanisławska I; Chmura-Skirlińska A; Dołowy K; Chłopicki S; Szewczyk A
Postepy Biochem; 2008; 54(2):198-208. PubMed ID: 18807931
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria: Targeting mitochondrial reactive oxygen species with mitochondriotropic polyphenolic-based antioxidants.
Teixeira J; Deus CM; Borges F; Oliveira PJ
Int J Biochem Cell Biol; 2018 Apr; 97():98-103. PubMed ID: 29454114
[TBL] [Abstract][Full Text] [Related]
15. Reactive Oxygen Species and the Aging Eye: Specific Role of Metabolically Active Mitochondria in Maintaining Lens Function and in the Initiation of the Oxidation-Induced Maturity Onset Cataract--A Novel Platform of Mitochondria-Targeted Antioxidants With Broad Therapeutic Potential for Redox Regulation and Detoxification of Oxidants in Eye Diseases.
Babizhayev MA; Yegorov YE
Am J Ther; 2016; 23(1):e98-117. PubMed ID: 21048433
[TBL] [Abstract][Full Text] [Related]
16. Targeted-mitochondria antioxidants therapeutic implications in inflammatory bowel disease.
Matondo A; Kim SS
J Drug Target; 2018 Jan; 26(1):1-8. PubMed ID: 28581825
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria-Targeted Antioxidants and Skeletal Muscle Function.
Broome SC; Woodhead JST; Merry TL
Antioxidants (Basel); 2018 Aug; 7(8):. PubMed ID: 30096848
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-targeted antioxidant peptides.
Rocha M; Hernandez-Mijares A; Garcia-Malpartida K; Bañuls C; Bellod L; Victor VM
Curr Pharm Des; 2010; 16(28):3124-31. PubMed ID: 20687871
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria-targeted Antioxidants as a Prospective Therapeutic Strategy for Multiple Sclerosis.
Fetisova E; Chernyak B; Korshunova G; Muntyan M; Skulachev V
Curr Med Chem; 2017; 24(19):2086-2114. PubMed ID: 28302008
[TBL] [Abstract][Full Text] [Related]
20. Generation of reactive oxygen species in the anterior eye segment. Synergistic codrugs of N-acetylcarnosine lubricant eye drops and mitochondria-targeted antioxidant act as a powerful therapeutic platform for the treatment of cataracts and primary open-angle glaucoma.
Babizhayev MA
BBA Clin; 2016 Dec; 6():49-68. PubMed ID: 27413694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
